KPV is a synthetic tripeptide composed of lysine, proline, and valine and represents a short peptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). KPV has become an area of laboratory research involving inflammatory signaling, immune-related pathways, epithelial biology, and cellular responses within gastrointestinal and dermal research models.

KPV research has explored its relationship with signaling mechanisms involved in inflammatory response and immune-cell communication. Researchers have examined its interactions with pathways associated with cytokine activity and cellular processes that contribute to the regulation of inflammatory signaling.

Another significant area of KPV research involves gastrointestinal and epithelial biology. Laboratory studies have investigated the peptide in models examining mucosal integrity, intestinal barrier-related processes, epithelial response, and communication between inflammatory and cellular signaling pathways.

KPV has a molecular weight of approximately 342.4 g/mol and can be synthetically produced for controlled research applications. This 10mg formulation is supplied in a nasal research format for laboratory investigation involving inflammatory signaling, epithelial biology, immune-related pathways, and associated cellular processes.